Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕HDFC Banking & Financial Services Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundHDFC Banking & Financial Services Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataHDFC
NAV₹40.2296₹20.5890
NAV date20 Nov 202620 Nov 2026
History10.9 years5.4 years
Expense ratio1.1%1.0%
Stars★★★★★★★★★★
Growth Score67.5057.70

Returns

Tata India Pharma & Healthcare FundHDFC Banking & Financial Services Fund
1 month+9.87%+11.85%
3 months+1.12%+6.19%
6 months+7.63%+13.64%
YTD+13.73%+6.75%
1 year+11.82%+6.91%
3 years (CAGR)+18.74%+14.98%
5 years (CAGR)+16.00%+13.47%
10 years (CAGR)+15.95%—
Since launch+13.58%+14.52%

Risk

Tata India Pharma & Healthcare FundHDFC Banking & Financial Services Fund
Volatility15.7%18.5%
Downside volatility10.0%11.3%
Sharpe0.780.46
Sortino1.230.75
Calmar1.120.88
Return / risk1.190.81
Deepest fall−19.84%−21.72%
Days to recover375148
Below its high+0.00%+0.00%

Against benchmark

Tata India Pharma & Healthcare FundHDFC Banking & Financial Services Fund
Alpha−2.76%+0.71%
Beta1.000.92
R²90.2%93.8%
Up capture91.7%93.2%
Down capture101.4%87.0%
Tracking error4.9%4.9%
Information ratio−0.570.00
Treynor0.110.08

Consistency

Tata India Pharma & Healthcare FundHDFC Banking & Financial Services Fund
Best 1-year+76.35%+40.29%
Middle 1-year+8.85%+14.57%
Worst 1-year−17.32%−5.78%
1-year periods with a loss29.0%4.7%
Middle 3-year+21.13%+16.70%
Positive months63.9%55.6%
Best day+3.34%+5.73%
Worst day−3.09%−7.80%
Worst 5% day−1.35%−1.55%
Positive days55.4%54.6%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundHDFC Banking & Financial Services Fund
5-year XIRR+18.07%+15.16%
5-year value₹9,50,065₹8,83,562
3-year XIRR+13.31%+13.11%
1-year XIRR+18.41%+16.89%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth